Lewis blood group biosynthesis
Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ. Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy. Front Oncol. 2018;8():150. PMID: 29795807; PMCID: PMC5958677.; Trinchera M, Aronica A, Dall'Olio F. Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers. Biology (Basel). 2017 Feb 23;6(1). PMID: 28241499; PMCID: PMC5372009.; Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med. 2016 Nov;8(6):517–35. PMID: 27599872; PMCID: PMC5061611.; Natoni A, Macauley MS, O’Dwyer ME. Targeting Selectins and Their Ligands in Cancer. Front. Oncol. 2016 Apr 18;6(). doi: 10.3389/fonc.2016.00093.; Cheung LS, Raman PS, Balzer EM, Wirtz D, Konstantopoulos K. Biophysics of selectin-ligand interactions in inflammation and cancer. Phys Biol. 2011 Feb;8(1):015013. doi: 10.1088/1478-3975/8/1/015013. PMID: 21301059.; Läubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010 Jun;20(3):169–77. doi: 10.1016/j.semcancer.2010.04.005. PMID: 20452433.; MAGNANI J. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Archives of Biochemistry and Biophysics. 2004 Jun;426(2):122–31. doi: 10.1016/s0003-9861(04)00214-0.; Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003 Jun;9(6):263–8. doi: 10.1016/s1471-4914(03)00071-6. PMID: 12829015.